Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ResoTher Pharma A/S
A/S
Active
Advertising protection
CVR 37852406
Dronninggårds Alle 136, 2840
Holte
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
5 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ResoTher Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AK
Anders Kronborg
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
HS
Henrik Stage
Board of Directors
Board of Directors
2017
SM
Sven Martin Jacobson
Board of Directors
Board of Directors
2021
RJ
Roderick John Flower
Board of Directors
Board of Directors
2023
RA
Rebecca Anne Morison
Chairman
Chairman
2025
JØ
Jeppe Øvli Øvlesen
Board of Directors
Board of Directors
2018
TE
Thomas Engelbrecht Nordkild Jonassen
Board of Directors
Board of Directors
2025
Former (4)
LH
Lars Henning Stigel
Board of Directors
Board of Directors
2019 – 2021
TF
Thomas Feldthus
Board of Directors
Board of Directors
2021 – 2025
MM
Mette Munch
Board of Directors
Board of Directors
2017 – 2019
KA
Kirsten Aarup Drejer
Chairman
Chairman
2018 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
TJ Biotech Holding ApS
Company
5–9.99%
5–9.99%
2021
Quantass ApS
Company
5–9.99%
5–9.99%
2021
Uddannelses- og Forskningsstyrelsen
Company
5–9.99%
5–9.99%
2021
Pinnacle Holding ApS
Company
5–9.99%
5–9.99%
2019
Lone Merete Veng
Individual
15–19.99%
15%
2017
Mauro Antonia Italo Perretti
Individual
5–9.99%
5–9.99%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ResoTher Pharma A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network